Boothbay Fund Management’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-30,570
Closed -$312K 2101
2023
Q2
$312K Buy
30,570
+14,167
+86% +$148K 0.01% 1279
2023
Q1
$149K Buy
16,403
+2,450
+18% +$18K ﹤0.01% 1825
2022
Q4
$100K Sell
13,953
-26,798
-66% -$164K ﹤0.01% 1785
2022
Q3
$266K Sell
40,751
-44,711
-52% -$239K 0.01% 1619
2022
Q2
$412K Sell
85,462
-1,173
-1% -$5.8K 0.01% 1279
2022
Q1
$492K Hold
86,635
0.01% 1301
2021
Q4
$435K Hold
86,635
0.01% 1076
2021
Q3
$576K Sell
86,635
-38,192
-31% -$228K 0.02% 1022
2021
Q2
$763K Sell
124,827
-9,689
-7% -$58.4K 0.03% 812
2021
Q1
$895K Sell
134,516
-16,183
-11% -$111K 0.05% 656
2020
Q4
$797K Sell
150,699
-1,542
-1% -$12.1K 0.04% 579
2020
Q3
$1.13M Buy
152,241
+30
+0% +$234 0.09% 393
2020
Q2
$1.12M Buy
152,211
+36,823
+32% +$323K 0.1% 354
2020
Q1
$854K Buy
+115,388
New +$837K 0.09% 338

Other funds holding SCPH